NeoMimix offers a natural method for sperm selection in assisted human reproduction, mimicking the female reproductive tract for optimal results. The technology replicates the female reproductive tract to sort and select top-quality, low DNA fragmented sperm in a straightforward and fully traceable manner. The startup operates in the Medical Devices industry and recently received a €40.00K Pre Seed Round investment on 02 June 2020, with the funding coming from EIT Health.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round | €40.00K | 1 | EIT Health | 02 Jun 2020 |
No recent news or press coverage available for Neomimix.